Form 4: Bicycle Therapeutics CFO Sells Shares
Insider Transaction (Form 4)
Travis Alvin Thompson, Chief Financial Officer of Bicycle Therapeutics Plc, sold 972 shares of common stock on October 2, 2026.
Summary
- Open-market sale: disposed of 893 Ordinary Shares at $3.47 ($3,099) on October 2, 2026; holds 64,528 after (Direct).
- Open-market sale: disposed of 79 Ordinary Shares at $3.57 ($282) on October 5, 2026; holds 64,449 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $3,381 of stock on the open market.
Insider Transactions
Travis Alvin Thompson — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Open-market sale | Ordinary Shares | 893 | $3 | $3.1K | 64,528 |
| 2026-10-05 | Open-market sale | Ordinary Shares | 79 | $4 | $282 | 64,449 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Open-market sale (893 shares) |
| 2026-10-05 | Open-market sale (79 shares) |
Keywords
insider transaction, Form 4, BCYC, BICYCLE THERAPEUTICS PLC, bearish, Travis Alvin Thompson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.